Stada rejects €3.6bn buyout offers, asks for more
Stada, the German pharmaceuticals firm, has invited private equity bidders to raise their offers for a potential buyout, after a board meeting this week. If the LBO occurs, it would be the largest in Europe since 2015.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts